www.medisonpharma.com Open in urlscan Pro
213.8.29.114  Public Scan

URL: https://www.medisonpharma.com/
Submission: On May 06 via manual from DE — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

 * About Us
 * Our Markets
 * Careers
 * Newsroom
 * Contact Us
 * Linkedin
 * © Copyright 2021 © Medison Pharma. All Rights Reserved.

ALWAYS

AHEAD

MEDISON IS A GLOBAL PHARMA COMPANY PROVIDING ACCESS TO HIGHLY INNOVATIVE
THERAPIES TO PATIENTS IN INTERNATIONAL MARKETS.


MEDISON CREATED THE FIRST MULTI-REGIONAL COMMERCIALIZATION PLATFORM TO
ACCELERATE ACCESS TO HIGHLY INNOVATIVE THERAPIES DEVELOPED BY LEADING BIOTECH
AND PHARMA COMPANIES, HELPING TO SAVE LIVES OF PATIENTS IN INTERNATIONAL MARKETS

 

Learn More
OUR PARTNERS



A UNIFIED ALLIANCE
ACROSS MARKETS

Medison is changing the commercialization paradigm for highly innovative
therapies in international markets. An affiliate-like multi-regional partnership
enables emerging biotech companies to accelerate product launches in
international markets while preserving their bandwidth to focus on main markets.

Learn More





A COMPREHENSIVE
COMMERCIALIZATION SUITE

Medison’s unique set of expertise, centralized alliance management capabilities,
global infrastructure and affiliate-like partnership model expands the
geographic reach of emerging biotech companies.


REGULATION & 
MARKET ACCESS 

Applying in-depth knowledge and expertise in regulatory frameworks and market
access processes to ensure that high budget, innovative products are reimbursed
and made available to patients.




EARLY ACCESS
PROGRAMS

Navigating local access complexities for Medison’s partners to make their
breakthrough therapies available for patients as quickly as possible.




MEDICAL
AFFAIRS

Applying scientific and medical know-how, as well as ties in the academic,
scientific and medical arenas to gain and disseminate insights and knowledge on
cutting-edge therapies.




MARKETING
& SALES

Empowering physicians to provide the latest and most suitable therapies to
patients by facilitating a customer-oriented approach and access to up-to-date
information.




PATIENT SUPPORT
PROGRAMS

Leveraging the latest therapies, techniques and clinical resources to train and
support patients, care partners and healthcare professionals, as well as improve
patient engagement and medication-taking behavior.




DISTRIBUTION
& LOGISTICS

Providing Medison’s partners with the convenience and peace of mind of a
complete end-to-end service, across all stages, from post-production to delivery
to patients.




A COMPREHENSIVE
COMMERCIALIZATION SUITE

Medison’s unique set of expertise, centralized alliance management capabilities,
global infrastructure and affiliate-like partnership model expands the
geographic reach of emerging biotech companies.


REGULATION & 
MARKET ACCESS 

Applying in-depth knowledge and expertise in regulatory frameworks and market
access processes to ensure that high budget, innovative products are reimbursed
and made available to patients.


EARLY ACCESS
PROGRAMS

Navigating local access complexities for Medison’s partners to make their
breakthrough therapies available for patients as quickly as possible.


MEDICAL
AFFAIRS

Applying scientific and medical know-how, as well as ties in the academic,
scientific and medical arenas to gain and disseminate insights and knowledge on
cutting-edge therapies.


MARKETING
& SALES

Empowering physicians to provide the latest and most suitable therapies to
patients by facilitating a customer-oriented approach and access to up-to-date
information.


PATIENT SUPPORT
PROGRAMS

Leveraging the latest therapies, techniques and clinical resources to train and
support patients, care partners and healthcare professionals, as well as improve
patient engagement and medication-taking behavior.


DISTRIBUTION
& LOGISTICS

Providing Medison’s partners with the convenience and peace of mind of a
complete end-to-end service, across all stages, from post-production to delivery
to patients.


OUR LATEST NEWS

Read More
28/03/22
Hansa Biopharma and Medison Pharma announce marketing authorization in Israel
for Idefirix[®] (imlifidase) for desensitization treatment of highly sensitized
kidney transplant patients
15/03/22
BeiGene and Medison Announce Approval and National Reimbursement in Israel for
BRUKINSA® (zanubrutinib) for the Treatment of Waldenström’s Macroglobulinemia
26/01/22
Victor Papamoniodis Joins Medison Pharma as VP International Markets
Read More
Always Ahead
 * Home
 * About Us
 * Medison Ventures
 * Compliance

 * Our Markets
 * Newsroom
 * Careers
 * Contact Us

 * linkedin

 * Privacy Policy
 * Cookies Policy
 * Terms of Use

© Copyright 2021 © Medison Pharma. All Rights Reserved.